EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inherent single-cell heterogeneity of the transcriptional response to hypoxia in cancer cells

Małgorzata Wilk, Thomas Knöpfel, Stana M Burger, Stellor Nlandu Khodo, Roland H Wenger iD

NAR Cancer · 2025

DOI: 10.1093/narcan/zcaf021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAR Cancer, 2025. Verfasst von Małgorzata Wilk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiology, University of Zürich, Zürich, CH-8057, Switzerland. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Proteins, Single-Cell Analysis, Hypoxia-Inducible Factor 1, alpha Subunit, Neoplasms. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxia-inducible factor (HIF) is a master regulator of cancer cell adaptation to tumor hypoxia and is involved in cancer progression. Single-cell (sc) differences in the HIF response allow for tumor evolution and cause therapy resistance. These sc-differences are usually ascribed to tumor microenvironmental differences and/or clonal (epi)genetic variability. However, the sc-heterogeneity of the HIF response in otherwise identical cells cultured under defined in vitro conditions has not yet been addressed. Therefore, we analyzed the sc-response to hypoxia in nonclonal cell lines and multiple clonal derivatives, including HIF-1α or HIF-2α knockouts. While HIF-1α and HIF-1 target mRNA sc-heterogeneity was slightly higher than global transcription or specific housekeeping messenger RNAs (mRNAs), HIF-2α and especially HIF-2 target mRNA sc-heterogeneity was extraordinary, and remained in independent clones following HIFα knockouts. Unexpectedly, neither HIF-2α mRNA nor nuclear protein levels correlated with target mRNA levels. Unsupervised but not supervised HIF target gene dimensionality reduction revealed the initial sample composition after scRNA-seq, demonstrating that, owing to sc-heterogeneity, individual HIF target genes are not sufficient to unequivocally identify hypoxic cancer cells. In conclusion, the pronounced intrinsic sc-heterogeneity of the HIF response represents a hitherto unrecognized feature of cancer cells that impairs clinical HIF pathway-dependent cancer cell identification and targeting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basic Helix-Loop-Helix ProteinsSingle-Cell AnalysisHypoxia-Inducible Factor 1, alpha SubunitNeoplasmsHumansCell Line, TumorGene Expression Regulation, NeoplasticRNA, MessengerTumor MicroenvironmentCell HypoxiaTranscription, GeneticTumor HypoxiaEndothelial PAS Domain-Containing Protein 1

Substanzen

Basic Helix-Loop-Helix ProteinsHypoxia-Inducible Factor 1, alpha SubunitRNA, MessengerEndothelial PAS Domain-Containing Protein 1HIF1A protein, human

Autor:innen und Institutionen

  • Institute of Physiology, University of Zürich, Zürich, CH-8057, Switzerland.

ORCID-Profile: Roland H Wenger

Förderung

  • Swiss National Science Foundation

Zitieren

APA

Wilk, M., Knöpfel, T., Burger, S. M., Khodo, S. N., & Wenger, R. H. (2025). Inherent single-cell heterogeneity of the transcriptional response to hypoxia in cancer cells. NAR Cancer. https://doi.org/10.1093/narcan/zcaf021

Vancouver

Wilk M, Knöpfel T, Burger SM, Khodo SN, Wenger RH. Inherent single-cell heterogeneity of the transcriptional response to hypoxia in cancer cells. NAR Cancer. 2025. doi:10.1093/narcan/zcaf021

BibTeX
@article{Wilk2025,
  author = {Wilk, Małgorzata and Knöpfel, Thomas and Burger, Stana M and Khodo, Stellor Nlandu and Wenger, Roland H},
  title = {Inherent single-cell heterogeneity of the transcriptional response to hypoxia in cancer cells},
  journal = {NAR Cancer},
  year = {2025},
  doi = {10.1093/narcan/zcaf021}
}
Kostenlos starten →